155 related articles for article (PubMed ID: 33912836)
1. PHarmacist Avoidance or Reductions in Medical Costs in Patients Presenting the EMergency Department: PHARM-EM Study.
Rech MA; Adams W; Smetana KS; Gurnani PK; Van Berkel Patel MA; Peppard WJ; Hammond DA; Flannery AH
Crit Care Explor; 2021 Apr; 3(4):e0406. PubMed ID: 33912836
[TBL] [Abstract][Full Text] [Related]
2. PHarmacist Avoidance or Reductions in Medical Costs in CRITically Ill Adults: PHARM-CRIT Study.
Rech MA; Gurnani PK; Peppard WJ; Smetana KS; Van Berkel MA; Hammond DA; Flannery AH
Crit Care Explor; 2021 Dec; 3(12):e0594. PubMed ID: 34913039
[TBL] [Abstract][Full Text] [Related]
3. Pharmacist Avoidance or Reductions in Medical Costs in Critically and Emergently Ill Pediatrics: PHARM-PEDS Study.
Kiskaddon AL; Smith MM; Gilliland F; Rech MA
Crit Care Explor; 2023 Oct; 5(10):e0980. PubMed ID: 37811129
[TBL] [Abstract][Full Text] [Related]
4. Evaluating reduction in medical costs associated with pharmacists' presence in the emergency department using a novel cost avoidance framework.
Poremba M; Champa K; Reichert E
Am J Health Syst Pharm; 2023 Aug; 80(Suppl 3):S111-S118. PubMed ID: 36525567
[TBL] [Abstract][Full Text] [Related]
5. Benefit of Incorporating Clinical Pharmacists in an Adult Intensive Care Unit: A Cost-saving Study.
Muñoz-Pichuante D; Villa-Zapata L
J Clin Pharm Ther; 2020 Oct; 45(5):1127-1133. PubMed ID: 32497354
[TBL] [Abstract][Full Text] [Related]
6. Emergency medicine pharmacist interventions reducing exposure to costs (EMPIRE-C).
Dietrich SK; Bushong BT; Schneider-Smith EA; Mixon MA
Am J Emerg Med; 2022 Apr; 54():178-183. PubMed ID: 35158260
[TBL] [Abstract][Full Text] [Related]
7. Cost-avoidance associated with implementation of an overnight emergency medicine pharmacist at a Level I Trauma, Comprehensive Stroke Center.
Nguyen MH; Gordon K; Reachi B; Bair J; Chauv S; Fontaine GV
Am J Emerg Med; 2024 May; 82():63-67. PubMed ID: 38805940
[TBL] [Abstract][Full Text] [Related]
8. Cost avoidance from health system specialty pharmacist interventions in patients with multiple sclerosis.
Georgieva D; Markley B; DeClercq J; Choi L; Zuckerman AD
J Manag Care Spec Pharm; 2024 Apr; 30(4):336-344. PubMed ID: 38555624
[TBL] [Abstract][Full Text] [Related]
9. A cost avoidance study of critical care pharmacists' interventions in a tertiary institution in Singapore.
Chan LEJ; Soong JL; Lie SA
Am J Health Syst Pharm; 2023 Feb; 80(5):267-283. PubMed ID: 36371740
[TBL] [Abstract][Full Text] [Related]
10. Integration of a clinical pharmacist into a Canadian, urban emergency department: a prospective observational study.
Dryden L; Dewhurst NF
Int J Pharm Pract; 2019 Apr; 27(2):175-179. PubMed ID: 30079985
[TBL] [Abstract][Full Text] [Related]
11. Documentation of pharmacists' interventions in an emergency department and associated cost avoidance.
Lada P; Delgado G
Am J Health Syst Pharm; 2007 Jan; 64(1):63-8. PubMed ID: 17189582
[TBL] [Abstract][Full Text] [Related]
12. A prospective trial of a clinical pharmacy intervention in a primary care practice in a capitated payment system.
Altavela JL; Jones MK; Ritter M
J Manag Care Pharm; 2008; 14(9):831-43. PubMed ID: 19006440
[TBL] [Abstract][Full Text] [Related]
13. Discharge prescription optimization by emergency medicine pharmacists in an academic emergency department in the United States.
Castillo J; Campbell MJ; Sokn E; Spinner M; Lam SW; Meldon S; Podolsky S
Int J Clin Pharm; 2021 Jun; 43(3):673-680. PubMed ID: 33124677
[TBL] [Abstract][Full Text] [Related]
14. A qualitative dual-site analysis of the pharmacist discharge care (PHARM-DC) intervention using the CFIR framework.
Murry LT; Keller MS; Pevnick JM; Schnipper JL; Kennelty KA;
BMC Health Serv Res; 2022 Feb; 22(1):186. PubMed ID: 35151310
[TBL] [Abstract][Full Text] [Related]
15. Implementation and Impact of Critical Care Pharmacist Addition to a Telecritical Care Network.
Belcher RM; Blair A; Chauv S; Hoang Q; Hickman AW; Peng M; Baldwin M; Koch L; Nguyen M; Guidry D; Fontaine GV
Crit Care Explor; 2023 Jan; 5(1):e0839. PubMed ID: 36660010
[TBL] [Abstract][Full Text] [Related]
16. Clinical and economic impact of pharmacist interventions in an ambulatory hematology-oncology department.
de Grégori J; Pistre P; Boutet M; Porcher L; Devaux M; Pernot C; L Chrétien M; Rossi C; Manfredi S; Dalac S; Gueneau P; Boulin M
J Oncol Pharm Pract; 2020 Jul; 26(5):1172-1179. PubMed ID: 32299314
[TBL] [Abstract][Full Text] [Related]
17. Analysis of pharmacist-provided medication therapy management (MTM) services in community pharmacies over 7 years.
Barnett MJ; Frank J; Wehring H; Newland B; VonMuenster S; Kumbera P; Halterman T; Perry PJ
J Manag Care Pharm; 2009; 15(1):18-31. PubMed ID: 19125547
[TBL] [Abstract][Full Text] [Related]
18. Impact of pharmacist's interventions on cost of drug therapy in intensive care unit.
Saokaew S; Maphanta S; Thangsomboon P
Pharm Pract (Granada); 2009 Apr; 7(2):81-7. PubMed ID: 25152782
[TBL] [Abstract][Full Text] [Related]
19. Economic impact of clinical pharmacist interventions in a general tertiary hospital in Qatar.
Abushanab D; Atchan M; Elajez R; Elshafei M; Abdelbari A; Al Hail M; Abdulrouf PV; El-Kassem W; Ademi Z; Fadul A; Abdalla E; Diab MI; Al-Badriyeh D
PLoS One; 2023; 18(6):e0286419. PubMed ID: 37262042
[TBL] [Abstract][Full Text] [Related]
20. The Role of the Clinical Pharmacist in a Preventive Cardiology Practice.
Warden BA; Shapiro MD; Fazio S
Ann Pharmacother; 2019 Dec; 53(12):1214-1219. PubMed ID: 31342786
[No Abstract] [Full Text] [Related]
[Next] [New Search]